Atrium Health Lincoln/LCI-Lincolnton is a clinical research site located in Lincolnton, North Carolina, United States 28092.
Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.
Atrium Health Lincoln/LCI-Lincolnton has participated in 21 clinical trials with 19 currently active.
Therapeutic areas: Prostate Cancer (Adenocarcinoma), Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma.
Sponsors: Canadian Cancer Trials Group, National Cancer Institute (NCI), SWOG Cancer Research Network.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Lincolnton
Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Atrium Health Lincoln/LCI-Lincolnton has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Atrium Health Lincoln/LCI-Lincolnton has 21 clinical trials on record, with 19 currently active. Their work covers Prostate Cancer (Adenocarcinoma), Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma.
Atrium Health Lincoln/LCI-Lincolnton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.